These effects in women are not uncommon, and they can be addressed with cosmetic surgery
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS)
Compared with the DPP-4i group, the GLP-1RA group exhibited modest benefits in terms of the composite cardiovascular outcome including cardiovascular death, MI, and ischemic stroke
While some individuals may tolerate treatment without immediate complications, skipping laboratory testing can result in: Missed contraindications (e.g., thyroid abnormalities, pancreatitis risk) Undetected metabolic conditions (e.g., insulin resistance, liver disease) Poorly tailored dosing and monitoring There are limited scenarios where recent lab data (within 36 months) may suffice, but initiating treatment without any clinical baseline is generally considered incomplete care
Read More: Benefits of B12 Shots Do Vitamin B12 Injections Really Help with Weight Loss, or Is It Just a Marketing Gimmick